BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18221321)

  • 1. Detection of Notch signaling molecules in ameloblastomas.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2008 Apr; 37(4):228-34. PubMed ID: 18221321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
    Kumamoto H; Ooya K
    Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors.
    Kumamoto H; Ooya K
    Oral Dis; 2007 Sep; 13(5):461-7. PubMed ID: 17714348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Jul; 35(6):345-51. PubMed ID: 16762015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch4 overexpression in ameloblastoma correlates with the solid/multicystic phenotype.
    Siar CH; Nagatsuka H; Chuah KS; Rivera RS; Nakano K; Ng KH; Kawakami T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):224-33. PubMed ID: 20659700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Notch receptor expression in bile duct development and disease.
    Flynn DM; Nijjar S; Hubscher SG; de Goyet Jde V; Kelly DA; Strain AJ; Crosby HA
    J Pathol; 2004 Sep; 204(1):55-64. PubMed ID: 15307138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-notch signaling in odontogenesis: correlation with cytodifferentiation and evidence for feedback regulation.
    Mitsiadis TA; Hirsinger E; Lendahl U; Goridis C
    Dev Biol; 1998 Dec; 204(2):420-31. PubMed ID: 9882480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of Notch receptors and their ligands in desmoplastic ameloblastoma.
    Siar CH; Nakano K; Han PP; Nagatsuka H; Ng KH; Kawakami T
    J Oral Pathol Med; 2010 Aug; 39(7):552-8. PubMed ID: 20337864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Sep; 36(8):488-94. PubMed ID: 17686008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
    Kumamoto H; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas.
    Kumamoto H; Ooya K
    Virchows Arch; 2004 Feb; 444(2):164-70. PubMed ID: 14714184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas.
    Kumamoto H; Kimi K; Ooya K
    J Oral Pathol Med; 2001 Nov; 30(10):596-602. PubMed ID: 11722709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.